Cargando…
Why do we keep reporting high-grade prostatic intraepithelial neoplasia (HGPIN)?
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Sociedade Brasileira de Urologia
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4871375/ https://www.ncbi.nlm.nih.gov/pubmed/27176181 http://dx.doi.org/10.1590/S1677-5538.IBJU.2016.02.02 |
Ejemplares similares
-
Chemoprevention of prostate cancer in men with high-grade prostatic intraepithelial neoplasia (HGPIN): a systematic review and adjusted indirect treatment comparison
por: Cui, Kang, et al.
Publicado: (2017) -
Risk of prostate cancer after detection of isolated high-grade prostatic intraepithelial neoplasia (HGPIN) on extended core needle biopsy: a UK hospital experience
por: Singh, Paras B, et al.
Publicado: (2009) -
Prostate Cancer Chemoprevention Targeting Men with High-Grade Prostatic Intraepithelial Neoplasia (HGPIN) and Atypical Small Acinar Proliferation (ASAP): Model for Trial Design and Outcome Measures
por: Kumar, Nagi, et al.
Publicado: (2012) -
High-Grade Prostatic Intraepithelial Neoplasia
por: Klink, Joseph C, et al.
Publicado: (2012) -
Clinical features and prognosis of prostate cancer with high-grade prostatic intraepithelial neoplasia
por: Lee, Donghyun, et al.
Publicado: (2015)